A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support

BACKGROUND: CCR5-coreceptor antagonists can be used for treating HIV-2 infected individuals. Before initiating treatment with coreceptor antagonists, viral coreceptor usage should be determined to ensure that the virus can use only the CCR5 coreceptor (R5) and cannot evade the drug by using the CXCR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Retrovirology
Main Authors: Döring, Matthias, Borrego, Pedro, Büch, Joachim, Martins, Andreia, Friedrich, Georg, Camacho, Ricardo Jorge, Eberle, Josef, Kaiser, Rolf, Lengauer, Thomas, Taveira, Nuno, Pfeifer, Nico
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5168878/
https://ncbi.nlm.nih.gov/pubmed/27998283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12977-016-0320-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados